Etiology and significance of the "Optically clear nucleus"

Endocrine Pathology

Volumn 13, Issue 4, 2002, Pages 289-299

  Baloch, Zubair W ^a   LiVolsi, Virginia A ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

Diagnosis; Immunohistochemistry; Papillary carcinoma; RET PTC

Indexed keywords

CANCER CYTODIAGNOSIS; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CHROMATIN STRUCTURE; CONFERENCE PAPER; GENETIC ANALYSIS; GEOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; METHODOLOGY; ONCOGENE RET; PRIORITY JOURNAL; PROTO ONCOGENE; RADIATION EXPOSURE; THYROID PAPILLARY CARCINOMA; TUMOR GROWTH;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037003418     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:13:4:289     Document Type: Conference Paper

References (88)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. Calif Cancer J Clin 48:6-29, 1998.
2. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9:421-427, 1999.
3. Hedinger CWE, Sobin LH. WHO: histologic typing of thyroid tumors. New York: Springer-Verlag, 1988.
4. LiVolsi VA. Surgical pathology of the thyroid. Philadelphia: W.B. Saunders, 1990.
5. Rosai J, Carcangui ML, DeLellis RA. Tumors of the thyroid gland. vol. 3rd Series, Fascicle 5. Washington, DC: Armed Forces Institute of Pathology, 1992.
6. LiVolsi VA. Papillary neoplasms of the thyroid: pathologic and prognostic features. Am J Clin Pathol 97:426-434, 1992.
7. Mazzaferi EYR. Papillary thyroid carcinoma: a 10-year follow-up report of the impact of therapy in 576 patients. Am J Med 70:511-518, 1981.
8. Carcangui MLZG, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid: a clinico-pathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805-828, 1985.
9. Sierk AE, Askin FB, Reddick RL, Thomas CG Jr. Pediatric thyroid cancer. Pediatr Pathol 10:877-893, 1990.
10. Lupoli G, Vitale G, Caraglia M, Fittipaldi MR, Abbruzzese A, Tagliaferri P, Bianco AR. Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353:637-639, 1999.
11. Chan JK. Papillary carcinoma of thyroid: classical and variants. Histol Histopathol 5:241-257, 1990.
12. Hapke MR, Dehner LP. The optically clear nucleus: a reliable sign of papillary carcinoma of the thyroid? Am J Surg Pathol 3:31-38, 1979.
13. Kini SR. Guides to clinical aspiration biopsy thyroid. 2nd ed. New York: Igaku-Shoin, 1996.
14. Baloch ZW, Sack MJ, Yu GH, Livolsi VA, Gupta PK. Fine-needle aspiration of thyroid: an institutional experience. Thyroid 8:565-569, 1998.
15. Baloch ZW, Gupta PK, Yu GH, Sack MJ, LiVolsi VA. Follicular variant of papillary carcinoma: cytologic and histologic correlation. Am J Clin Pathol 111:216-221, 1999.
16. Johannessen JV, Gould VE, Jao W. The fine structure of human thyroid cancer. Hum Pathol 9:385-400, 1978.
17. Johannessen JV, Sobrinho-Simoes M, Finseth I, Pilstrom L. Ultrastructural morphometry of thyroid neoplasms. Am J Clin Pathol 79:166-171, 1983.
18. Kaneko C, Shamoto M, Niimi H, Osada A, Shimizu M, Shinzato M. Studies on intranuclear inclusions and nuclear grooves in papillary thyroid cancer by light, scanning electron and transmission electron microscopy. Acta Cytol 40:417-422, 1996.
19. Johannessen JV, Sobrinoes M, Lindmo T, Tangen KO, Kaalhus O, Brennhovd IO. Anomalous papillary carcinoma of the thyroid. Cancer 51:1462-1467, 1983.
20. Johannessen JV, Sobrinho-Simoes M, Finseth I, Pilstrom L. Papillary carcinomas of the thyroid have pore-deficient nuclei. Int J Cancer 30:409-411, 1982.
21. Lam AK, Montone KT, Nolan KA, Livolsi VA. Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histological parameters. Hum Pathol 29:565-568, 1998.
22. Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 83:4116-4122, 1998.
23. Tallini G, Santoro M, Helle M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML, Fusco A. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res 4:287-294, 1998 (see comments).
24. Elisei R, Romei C, Soldatenko PP, Cosci B, Vorontsova T, Vivaldi A, Basolo F, Cherstvoy ED, Pinchera A, Pacini F. New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post-Chernobyl papillary thyroid carcinoma. Clin Endocrinol 53:131-136, 2000.
25. Giannini R, Salvatore G, Monaco C, Sferratore F, Pollina L, Pacini F, Basolo F, Fusco A, Santoro M. Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis. Int J Oncol 16:485-489, 2000.
26. Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86:3211-3216, 2001.
27. Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL. Molecular genetic analysis refines the fine needle aspiration diagnosis of thyroid cancer. Mod Pathol 14:74A, 2001.
28. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, Vecchio G. One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol 7:3365-3370, 1987.
29. Fusco A, Grieco M, Santoro M, Berlingieri MT, Pilotti S, Pierotti MA, Della Porta G, Vecchio G. A new oncogene in human thyroid papillary carcinomas and their lymphnodal metastases. Nature 328:170-172, 1987.
30. Jhiang SM, Cho JY, Furminger TL, Sagartz JE, Tong Q, Capen CC, Mazzaferri EL. Thyroid carcinomas in RET/PTC transgenic mice. Recent Results Cancer Res 154:265-270, 1998.
31. Cho JY, Sagartz JE, Capen CC, Mazzaferri EL, Jhiang SM. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice. Oncogene 18:3659-3665, 1999.
32. Fischer AH, Bond JA, Taysavang PO, Eugene B, Wynford-Thomas D. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol 153:1443-1450, 1998.
33. Fusco A, Santoro M, Grieco M, Carlomagno F, Dathan N, Fabien N, Berlingieri MT, Li Z, De Franciscis V, Salvatore D, et al. RET/PTC activation in human thyroid carcinomas. J Endocrinol Invest 18:127-129, 1995.
34. Jhiang SM. The RET protooncogene in human cancers. Oncogene 19:5590-5597, 2000.
35. Jhiang SM, Caruso DR, Gilmore E, Ishizaka Y, Tahira T, Nagao M, Chiu IM, Mazzaferri EL. Detection of the PTC/retTPC oncogene in human thyroid cancers. Oncogene 7:1331-1337, 1992.
36. Jhiang SM, Mazzaferri EL. The ret/PTC oncogene in papillary thyroid carcinoma. J Lab Clin Med 123:331-337, 1994.
37. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, Xing S, Ledent C. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137:375-378, 1996.
38. Basolo F, Giannini R, Monaco C, et al. Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. Am J Pathol 160:247-254, 2002.
39. Chiappetta G, Toti P, Cetta F, Giuliano A, Pentimalli F, Amendola I, Lazzi S, Monaco M, Mazzuchelli L, Tosi P, Santoro M, Fusco A. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J Clin Endocrinol Metab 87:364-369, 2002.
40. Fabien N, Paulin C, Santoro M, Berger N, Grieco M, Galvain D, Barbier Y, Dubois PM, Fusco A. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation. Br J Cancer 66:1094-1098, 1992.
41. Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM, Rothstein JL. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 107:95-100, 1997 (see comments).
42. Sheils OM, O'Leary JJ, Sweeney EC. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR. J Pathol 192:32-36, 2000.
43. Santoro M, Papotti M, Chiappetta G, et al. RET activation and clinicopathologic features in poorly differentiated thyroid tumors. J Clin Endocrinol Metab 87:370-379, 2002.
44. Kini SR, Miller JM, Hamburger JI, Smith-Purslow MJ. Cytopathology of follicular lesions of the thyroid gland. Diagn Cytopathol 1:123-132, 1985.
45. Baloch ZW, LiVolsi VA. Warthin-like papillary carcinoma of the thyroid. Arch Pathol Lab Med 124:1192-1195, 2000.
46. Di Pasquale M, Rothstein JL, Palazzo JP. Pathologic features of Hashimoto's-associated papillary thyroid carcinomas. Hum Pathol 32:24-30, 2001.
47. Dugan JM, Atkinson BF, Avitabile A, Schimmel M, LiVolsi VA. Psammoma bodies in fine needle aspirate of the thyroid in lymphocytic thyroiditis. Acta Cytologica 31:330-334, 1987.
48. Emmrich P, Gauer G, Gauer J, Mattig H, Rosenkranz M. A comparative study of cytological and histological studies of the thyroid gland. Zentralbl Chir 126:267-272, 2001.
49. Baloch ZW, Solomon AC, LiVolsi VA. Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: a report of nine cases. Mod Pathol 13:802-807, 2000.
50. Behar R, Arganini M, Wu TC, McCormick M, Straus FHD, DeGroot LJ, Kaplan EL. Graves' disease and thyroid cancer. Surgery 100:1121-1127, 1986.
51. Fadda G, LiVolsi VA. Histology and aspiration cytology of benign thyroid diseases. Rays 24:182-196, 1999.
52. Konno N, Abe S, Uematsu T, Kanaya A, Wakabayashi J. Evaluation of fine needle aspiration cytology in the diagnosis of thyroid diseases. Hokkaido Igaku Zasshi - Hokkaido J Med Sci 64:186-194, 1989.
53. Livolsi VA, Merino MJ. Histopathologic differential diagnosis of the thyroid. Pathol Annu 16:357-406, 1981.
54. Soh EY, Park CS. Diagnostic approach to thyroid carcinoma in Graves' disease. Yonsei Med J 34:191-194, 1993.
55. Carney JA, Ryan J, Goellner JR. Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 11:583-591, 1987.
56. Heimann R, Demeester-Mirkine N, Van Sande J, Dumont JE. Hyalinizing trabecular adenoma. Am J Surg Pathol 13:808-810, 1989 (see comments).
57. Goellner JR, Carney JA. Cytologic features of fine-needle aspirates of hyalinizing trabecular adenoma of the thyroid. Am J Clin Pathol 91:115-119, 1989.
58. Katoh R, Jasani B, Williams ED. Hyalinizing trabecular adenoma of the thyroid: a report of three cases with immunohistochemical and ultrastructural studies. Histopathology 15:211-224, 1989.
59. Sambade C, Sarabando F, Nesland JM, Sobrinho Simoes M. Hyalinizing trabecular adenoma of the thyroid (case of the Ullensvang course): hyalinizing spindle cell tumor of the thyroid with dual differentiation (variant of the so-called hyalinizing trabecular adenoma). Ultrastruct Pathol 13:275-280, 1989.
60. Chan JK, Tse CC, Chiu HS. Hyalinizing trabecular adenoma-like lesion in multinodular goitre. Histopathology 16:611-614, 1990.
61. Cheung CC, Boerner SL, MacMillan CM, Ramyar L, Asa SL. Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 24:1622-1626, 2000.
62. Papotti M, Volante M, Giuliano A, Fassina A, Fusco A, Bussolati G, Santoro M, Chiappetta G. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol 24:1615-1621, 2000.
63. Fonseca E, Nesland JM, Sobrinho-Simoes M. Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid. Histopathology 31:330-335, 1997.
64. Baloch ZW, LiVolsi VA. Oncocytic lesions of the neuroendocrine system. Semin Diagn Pathol 16:190-199, 1999.
65. Silverman JF, West RL, Larkin EW, et al. The role of fine-needle aspiration biopsy in the rapid diagnosis and management of thyroid neoplasms. Cancer 57:1164-1170, 1986.
66. LiVolsi VA, Merino MJ. Worrisome histologic alterations following fine-needle aspiration of the thyroid (WHAFFT). Pathol Annu 29:99-120, 1994.
67. Baloch ZW, LiVolsi VA. Post fine-needle aspiration histologic alterations of thyroid revisited. Am J Clin Pathol 112:311-316, 1999.
68. Basolo F, Baloch ZW, Baldanzi A, Miccoli P, LiVolsi VA. Usefulness of Ultrafast Papanicolaou-stained scrape preparations in intraoperative management of thyroid lesions. Mod Pathol 12:653-657, 1999.
69. Aguilar M. Use of aspiration cytology and frozen section examination for management of benign and malignant thyroid nodules. Cancer 70:903, 904, 1992 (letter, comment).
70. Bronner MP, Hamilton R, LiVolsi VA. Utility of frozen section analysis on follicular lesions of the thyroid. Endocr Pathol 5:154-161, 1994.
71. Logani S, Gupta PK, LiVolsi VA, Mandel S, Baloch ZW. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management. Diagn Cytopathol 23:380-385, 2000.
72. Williams ED, Abrosimov A, Bogdanova TI, Roasi J, Sidorov Y, Thomas GA. Two proposals regarding the terminology of thyroid tumors: guest editorial. Int J Surg Pathol 8:181-183, 2000.
73. Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117:143-150, 20O2.
74. Chan JK. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 117:16-18, 2002.
75. Renshaw AA, Gould EW. Why there is tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 117:19-21, 2002.
76. Baloch ZW, Gupta PK, Yu GH, Sack MJ, LiVolsi VA. Follicular variant of papillary carcinoma: cytologic and histologic correlation. Am J Clin Pathol 111:216-222, 1999.
77. Albores-Saavedra JGE, Vardaman C, Vuitch F. The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol 22:1195-1205, 1991.
78. Baloch ZW, LiVolsi VA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol 13:861-865, 2000.
79. Baloch ZW, Abraham S, Roberts S, LiVolsi VA. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Hum Pathol 30:1166-1171, 1999.
80. Chu PG, Lyda MH, Weiss LM. Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours. Histopathology 39:9-16, 2001.
81. Judkins AR, Roberts SA, Livolsi VA. Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors. Hum Pathol 30:1373-1376, 1999.
82. Rigau V, Martel B, Evrard C, Rousselot P, Galateau-Salle F. Interet de l'HBME-1 en pathologie thyroidienne. Annales Pathologie 21:15-20, 2001.
83. Sack MJ, Astengo-Osuna C, Lin BT, Battifora H, LiVolsi VA. HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod Pathol 10:668-674, 1997.
84. van Hoeven KH, Kovatich AJ, Miettinen M. Immunocytochemical evaluation of HBME-1, CA 19-9, and CD-15 (Leu-M1) in fine-needle aspirates of thyroid nodules. Diagn Cytopathol 18:93-97, 1998.
85. Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 14:338-342, 2001.
86. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G. PTC is a novel rearranged form of the ret protooncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557-563, 1990.
87. Zou M, Shi Y, Farid NR. Low rate of ret protooncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer 73:176-180, 1994.
88. Thomas GA, Bunnell H, Cook HA, et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84:4232-4238, 1999.